Clinical trials recruiting in Esbjerg, Denmark

Phase breakdown

Conditions recruiting in Esbjerg, Denmark

Recruiting trials in Esbjerg, Denmark

• A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without Fractures
  NCT06864130 · Phase: Phase 4 · Ages: No age limits stated · Sex: Female
• A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
  NCT07662109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
  NCT07499232 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
  NCT06233461 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
  NCT06807424 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
  NCT07225504 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
  NCT07082738 · Phase: Phase 2 · Ages: 40 Years and older · Sex: All (male and female)
• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
  NCT07503210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
  NCT03968393 · Phase: Phase 4 · Ages: 55 Years and older · Sex: All (male and female)
• Blood Clotting Markers and Heart Ultrasound in People With Device-Detected Atrial Fibrillation
  NCT07713615 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female)
• Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?
  NCT06896682 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy
  NCT03730922 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
  NCT06877949 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
  NCT06882993 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female)
• Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
  NCT06790225 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female)
• Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
  NCT05448547 · Phase: Phase 3 · Ages: 75 Years and older · Sex: Male
• Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial
  NCT06309238 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female)
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Mediterranean Diet and Inequality in Early Breast Cancer
  NCT07007169 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Predictive Utility of a Short-term Improvement in Objectively Measured Physical Activity in Rheumatoid Arthritis (PUSIPA)
  NCT06289114 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Prehabilitation to Patients With Prostate Cancer
  NCT07162987 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Prognostic Significance of Fatty Liver Disease in Bariatric Patients
  NCT03535142 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease
  NCT05176132 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female)
• Strategy for Prompt and Effective Thoracentesis in the Emergency Department
  NCT06180603 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
  NCT06949319 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
  NCT03862859 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female)
• The Effect of Music During Colonoscopy
  NCT07454993 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• What Influence Re-participation in the Danish Colorectal Screening Program.
  NCT07353632 · Phase: Not specified · Ages: 50 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Esbjerg, Denmark?

33 recruiting trials have at least one study site in Esbjerg, Denmark.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.